{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:16:14Z","timestamp":1767849374167,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Finland has the world\u2019s highest incidence of 62.5\/100000 of diabetes mellitus type 1 (DM1) with approximately 400 (1%) DM1 pregnancies annually. Pregnancies complicated by DM1 are accompanied with increased risk for perinatal morbidity and mortality. Timing and mode of delivery are based on the risk of complications, yet the data on labor induction is limited. The aim of this study was to compare delivery outcomes in planned vaginal (VD) and planned cesarean deliveries (CD) in late preterm and term DM1 pregnancies, and to evaluate the feasibility of labor induction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and Methods<\/jats:title>\n                <jats:p>Pregnant women with DM1, live singleton fetus in cephalic presentation \u226534 gestational weeks delivering in Helsinki University Hospital between January 1st 2017 and December 31st 2019 were included. The primary outcome were the rates of adverse maternal and perinatal outcome. The study population was classified according to the 1980-revised White\u2019s classification. Statistical analyses were performed by IBM SPSS Statistics for Windows.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Two hundred four women were included, 59.8% (<jats:italic>n<\/jats:italic>\u00a0=\u2009122) had planned VD. The rate of adverse maternal outcome was 27.5% (<jats:italic>n<\/jats:italic>\u00a0=\u200956), similar between the planned modes of delivery and White classes. The rate of perinatal adverse outcome was 38.7% (<jats:italic>n<\/jats:italic>\u00a0=\u200979), higher in planned CD (52.4% vs. 29.5%;<jats:italic>p<\/jats:italic>\u00a0=\u20090.001). The most common adverse perinatal event was respiratory distress (48.8% vs. 23.0%;<jats:italic>p<\/jats:italic>\u00a0&lt;\u2009\u00a00.001). The rate of adverse perinatal outcome was higher in White class D\u2009+\u2009Vascular compared to B\u2009+\u2009C (45.0% vs. 25.0%, OR after adjustment by gestational age 2.34 [95% CI 1.20\u20134.50];<jats:italic>p<\/jats:italic>\u00a0=\u20090.01). The total rate of CD was 63.7% (<jats:italic>n<\/jats:italic>\u00a0=\u2009130), and 39.3% (<jats:italic>n<\/jats:italic>\u00a0=\u200948) in planned VD. Women with White class D\u2009+\u2009Vascular more often had emergency CD compared to White Class B\u2009+\u2009C (48.6% vs. 25.0%;<jats:italic>p<\/jats:italic>\u00a0=\u20090.009). The rate of labor induction was 51%, being 85.2% in planned VD. The rate of VD in induced labor was 58.7% (<jats:italic>n<\/jats:italic>\u00a0=\u200961) and the rate of failed induction was 14.1% (<jats:italic>n<\/jats:italic>\u00a0=\u200915).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Planned VD was associated with lower rate of adverse perinatal outcome compared to planned CS, with no difference in the rates of adverse maternal outcome. Induction of labor may be feasible option but should be carefully considered in this high-risk population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-04510-8","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:02:31Z","timestamp":1646233351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Planned vaginal and planned cesarean delivery outcomes in pregnancies complicated with pregestational type 1 diabetes \u2013 A three-year academic tertiary hospital cohort study"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0350-7088","authenticated-orcid":false,"given":"Heidi","family":"Kruit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saara","family":"Mertsalmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leena","family":"Rahkonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"issue":"4","key":"4510_CR1","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1001\/jama.2013.8399","volume":"310","author":"V Harjutsalo","year":"2013","unstructured":"Harjutsalo V, Sund R, Knip M. Incidence of type 1 diabetes in Finland. JAMA. 2013;310(4):427\u20138. https:\/\/doi.org\/10.1001\/jama.2013.8399.","journal-title":"JAMA."},{"issue":"Suppl 6","key":"4510_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1399-5448.2007.00280.x","volume":"8","author":"G Soltesz","year":"2007","unstructured":"Soltesz G, Patterson CC, Dahlquist G, EURODIAB Study Group. Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology? Pediatr Diabetes. 2007;8(Suppl 6):6\u201314 PDI280.","journal-title":"Pediatr Diabetes"},{"key":"4510_CR3","volume-title":"Perinatal statistics: Parturients, deliveries and newborns 2018","author":"E Vuori","year":"2019","unstructured":"Vuori E, Gissler M, National institute of Finland for Health and Welfare. Perinatal statistics: Parturients, deliveries and newborns 2018. 2019."},{"issue":"4","key":"4510_CR4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1471-0528.2007.01644","volume":"115","author":"R Bell","year":"2008","unstructured":"Bell R, Bailey K, Cresswell T, et al. Trends in prevalence and outcomes of pregnancy in women with pre-existing type I and type II diabetes. BJOG. 2008;115(4):445\u201352. https:\/\/doi.org\/10.1111\/j.1471-0528.2007.01644.","journal-title":"BJOG."},{"issue":"6","key":"4510_CR5","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.2337\/dc13-2717","volume":"37","author":"DS Feig","year":"2014","unstructured":"Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: A large, population-based study in ontario, canada, 1996-2010. Diabetes Care. 2014;37(6):1590\u20136. https:\/\/doi.org\/10.2337\/dc13-2717.","journal-title":"Diabetes Care"},{"key":"4510_CR6","volume-title":"Gestational diabetes. Current care guidelines","author":"Working group set up by the Finnish Medical Society Duodecim and the Finnish Cardiac Society","year":"2013","unstructured":"Working group set up by the Finnish Medical Society Duodecim and the Finnish Cardiac Society. Gestational diabetes. Current care guidelines. Helsinki: The Finnish medical society Duodecimwww.kaypahoito.fi. Updated 17.06. Accessed 15 Oct 2016; 2013."},{"issue":"Suppl 1","key":"4510_CR7","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.2337\/dc21-S014","volume":"44","author":"American Diabetes Association","year":"2021","unstructured":"American Diabetes Association. 14. management of diabetes in pregnancy: Standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S200\u201310. https:\/\/doi.org\/10.2337\/dc21-S014.","journal-title":"Diabetes Care"},{"issue":"5","key":"4510_CR8","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/0002-9343(49)90382-4","volume":"7","author":"P White","year":"1949","unstructured":"White P. Pregnancy complicating diabetes. Am J Med. 1949;7(5):609\u201316 0002-9343(49)90382-4.","journal-title":"Am J Med"},{"issue":"2","key":"4510_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/0002-9378(78)90373-3","volume":"130","author":"P White","year":"1978","unstructured":"White P. Classification of obstetric diabetes. Am J Obstet Gynecol. 1978;130(2):228\u201330 0002-9378(78)90373-3.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"4510_CR10","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/AOG.0000000000000820","volume":"125","author":"SN Bennett","year":"2015","unstructured":"Bennett SN, Tita A, Owen J, Biggio JR, Harper LM. Assessing white's classification of pregestational diabetes in a contemporary diabetic population. Obstet Gynecol. 2015;125(5):1217\u201323. https:\/\/doi.org\/10.1097\/AOG.0000000000000820.","journal-title":"Obstet Gynecol"},{"issue":"9987","key":"4510_CR11","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1016\/S0140-6736(14)61904-8)","volume":"385","author":"M Boulvain","year":"2015","unstructured":"Boulvain M, Senat MV, Perrotin F, Winer N, Beucher G, Subtil D, et al. Induction of labour versus expectant management for large-for-date fetuses: a randomised controlled trial. Lancet. 2015;385(9987):2600\u20135. https:\/\/doi.org\/10.1016\/S0140-6736(14)61904-8).","journal-title":"Lancet."},{"issue":"3","key":"4510_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ajog.2014.01.026","volume":"210","author":"AB Caughey","year":"2014","unstructured":"American College of Obstetricians and Gynecologists (College), Society for Maternal-Fetal Medicine, Caughey AB, Cahill AG, Guise JM, Rouse DJ. Safe prevention of the primary caesarean delivery. Am J Obstet Gynecol. 2014;210(3):179\u201393. https:\/\/doi.org\/10.1016\/j.ajog.2014.01.026.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"4510_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1471-0528.2003.02021.x","volume":"110","author":"CT Pham","year":"2003","unstructured":"Pham CT, Crowther CA. Birth outcomes: Utility values that postnatal women, midwives and medical staff express. BJOG. 2003;110(2):121\u20137 S147003280202921X.","journal-title":"BJOG."},{"key":"4510_CR14","doi-asserted-by":"publisher","first-page":"310239","DOI":"10.1155\/2015\/310239","volume":"2015","author":"AM Egan","year":"2015","unstructured":"Egan AM, McVicker L, Heerey A, Carmody L, Harney F, Dunne FP. Diabetic retinopathy in pregnancy: A population-based study of women with pregestational diabetes. J Diabetes Res. 2015;2015:310239. https:\/\/doi.org\/10.1155\/2015\/310239.","journal-title":"J Diabetes Res"},{"issue":"4","key":"4510_CR15","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0002-9378(11)90608-5","volume":"166","author":"B Rosenn","year":"1992","unstructured":"Rosenn B, Miodovnik M, Kranias G, et al. Progression of diabetic retinopathy in pregnancy: Association with hypertension in pregnancy. Am J Obstet Gynecol. 1992;166(4):1214\u20138 S0002-9378(11)90608-5.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"4510_CR16","doi-asserted-by":"publisher","first-page":"333.e1","DOI":"10.1016\/j.ajog.2012.06.066","volume":"207","author":"KE Yanit","year":"2012","unstructured":"Yanit KE, Snowden JM, Cheng YW, Caughey AB. The impact of chronic hypertension and pregestational diabetes on pregnancy outcomes. Am J Obstet Gynecol. 2012;207(4):333.e1\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2012.06.066.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"4510_CR17","first-page":"802","volume":"82","author":"CA Combs","year":"1993","unstructured":"Combs CA, Rosenn B, Kitzmiller JL, Khoury JC, Wheeler BC, Miodovnik M. Early-pregnancy proteinuria in diabetes related to preeclampsia. Obstet Gynecol. 1993;82(5):802\u20137.","journal-title":"Obstet Gynecol"},{"issue":"2","key":"4510_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12020-016-1134-z","volume":"55","author":"K Cyganek","year":"2017","unstructured":"Cyganek K, Skupien J, Katra B, et al. Risk of macrosomia remains glucose-dependent in a cohort of women with pregestational type 1 diabetes and good glycaemic control. Endocrine. 2017;55(2):447\u201355. https:\/\/doi.org\/10.1007\/s12020-016-1134-z.","journal-title":"Endocrine."},{"issue":"5","key":"4510_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2337\/dc08-9020","volume":"31","author":"JL Kitzmiller","year":"2008","unstructured":"Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: Summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060\u201379. https:\/\/doi.org\/10.2337\/dc08-9020.","journal-title":"Diabetes Care"},{"key":"4510_CR20","doi-asserted-by":"publisher","unstructured":"Macrosomia: ACOG practice bulletin, number 216. Obstet Gynecol. 2020;135(1):e18\u201335. https:\/\/doi.org\/10.1097\/AOG.0000000000003606.","DOI":"10.1097\/AOG.0000000000003606"},{"issue":"8","key":"4510_CR21","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1111\/dom.13310","volume":"20","author":"DN Voormolen","year":"2018","unstructured":"Voormolen DN, DeVries JH, Sanson RME, et al. Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): A multicentre randomized controlled trial. Diabetes Obes Metab. 2018;20(8):1894\u2013902. https:\/\/doi.org\/10.1111\/dom.13310.","journal-title":"Diabetes Obes Metab"},{"issue":"10110","key":"4510_CR22","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","volume":"390","author":"DS Feig","year":"2017","unstructured":"Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): A multicentre international randomised controlled trial. Lancet. 2017;390(10110):2347\u201359 S0140-6736(17)32400-5.","journal-title":"Lancet."},{"issue":"3","key":"4510_CR23","first-page":"137","volume":"22","author":"R Yoeli-Ullman","year":"2020","unstructured":"Yoeli-Ullman R, Dori-Dayan N, Mazaki-Tovi S, et al. Towards implementation of the saint vincent declaration: Outcomes of women with pregestational diabetes. Isr Med Assoc J. 2020;22(3):137\u201341.","journal-title":"Isr Med Assoc J"},{"issue":"3","key":"4510_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1055\/s-0029-1239487","volume":"27","author":"VB Dharan","year":"2010","unstructured":"Dharan VB, Srinivas SK, Parry S, Ratcliffe SJ, Macones G. Pregestational diabetes: A risk factor for vaginal birth after caesarean section failure? Am J Perinatol. 2010;27(3):265\u201370. https:\/\/doi.org\/10.1055\/s-0029-1239487.","journal-title":"Am J Perinatol"},{"issue":"16","key":"4510_CR25","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1080\/14767058.2018.1557143","volume":"33","author":"RAJ McLaren","year":"2020","unstructured":"McLaren RAJ, Ndubizu C, Atallah F, Minkoff H. Association of uterine rupture with pregestational diabetes in women undergoing trial of labour after caesarean delivery. J Matern-Fet Neonat Med. 2020;33(16):2697\u2013703.","journal-title":"J Matern-Fet Neonat Med"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-04510-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-04510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T15:02:40Z","timestamp":1646233360000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-04510-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4510"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-04510-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the institutional review board of the hospital region (Helsinki and Uusimaa Hospital District Committee for Obstetrics and Gynecology, HUS\/3172\/2018 and HUS\/54\/2019). Due to the retrospective nature of the study, written informed consent was waived according to national legislation (Medical Research Act 488\/1999, chapter 2 a (23.4.2004\/295), section 5 and 10a). The study was performed with the relevant guidelines and regulations and in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}